4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-25-019632
CFO & Head of Corp Development acquired 147,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ghias Babar · CFO & Head of Corp Development
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-24 | Grant or award : show line 1 in the form | +147,000 | 147,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-24 | Grant or award : show line 2 in the form Emp. Stock Option (Right to Buy) | +305,000 | 305,000 | D |
Loading xslF345X05/form4.xml…